REVEAL: A Phase 3 Study of ION582 in Angelman Syndrome

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(37 sites)

United States

Cedars-Sinai Medical Center, Los Angeles, California

Rady Children's Hospital, San Diego, California

Colorado Children's Hospital Research Institute, Aurora, Colorado

Children's National Hospital, Washington D.C., District of Columbia

Nicklaus Children's Hospital, Miami, Florida